Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes

RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation

(2014) Y. Chen et al.   JOURNAL OF IMMUNOLOGY

Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice

(2010) S. REDDY et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Localized Amyloidosis at the Site of Repeated Insulin Injection in a Diabetic Patient

(2010) Yasuyoshi Shikama et al.   INTERNAL MEDICINE

The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

(2009) P.-H. Groop et al.   DIABETES

Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels

(2009) Katrien H. J. Gaens et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fructose-1,6-Bisphosphatase Overexpression in Pancreatic  -Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of  -Cell Function

(2008) M. Kebede et al.   DIABETES

Extracellular High-Mobility Group Box 1 Acts as an Innate Immune Mediator to Enhance Autoimmune Progression and Diabetes Onset in NOD Mice

(2008) J. Han et al.   DIABETES

The Rising Incidence of Type 1 Diabetes Is Accounted for by Cases With Lower-Risk Human Leukocyte Antigen Genotypes

(2008) S. Fourlanos et al.   DIABETES CARE

Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases

(2008) Ling Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study

(2008) Valma Harjutsalo et al.   LANCET

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

(2008) Kirsti Näntö-Salonen et al.   LANCET